These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 21844486
1. Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea. Egan BM. Hypertension; 2011 Oct; 58(4):542-3. PubMed ID: 21844486 [No Abstract] [Full Text] [Related]
2. Renal denervation for sleep apnea and resistant hypertension: alternative or complementary to effective continuous positive airway pressure treatment? Tsioufis C, Papademetriou V, Thomopoulos C, Stefanadis C. Hypertension; 2011 Dec; 58(6):e191; author reply e192. PubMed ID: 22042808 [No Abstract] [Full Text] [Related]
3. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482 [Abstract] [Full Text] [Related]
4. Obstructive sleep apnoea, resistant hypertension and renal denervation. Witkowski A, Kadziela J. EuroIntervention; 2013 May; 9 Suppl R():R105-9. PubMed ID: 23732140 [Abstract] [Full Text] [Related]
5. Encouraging Results of Renal Denervation in Resistant Hypertension Patients With Obstructive Sleep Apnea. Kumagai H, Oshima N. Circ J; 2016 May 25; 80(6):1316-8. PubMed ID: 27170201 [No Abstract] [Full Text] [Related]
6. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states. McArdle MJ, deGoma EM, Cohen DL, Townsend RR, Wilensky RL, Giri J. J Am Heart Assoc; 2015 Mar 23; 4(3):e001415. PubMed ID: 25801757 [No Abstract] [Full Text] [Related]
18. Metabolic effects of renal denervation. Thomopoulos C, Spanoudi F, Kyriazis I, Anastasopoulos I, Ioannidis I. Curr Clin Pharmacol; 2013 Aug 23; 8(3):206-11. PubMed ID: 23173965 [Abstract] [Full Text] [Related]
19. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation. Wang Y. Int J Cardiol; 2014 Oct 20; 176(3):1262-3. PubMed ID: 25115259 [No Abstract] [Full Text] [Related]